Cardiovascular & Hematological Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Volume 2 - Number 2
Vascular Effects of Antiarrhythmic Drugs and the Roles of K+ Channels
, 2(2): 99 - 106
H. Kinoshita and Y. Hatano
DOI: 10.2174/1568016043477279
Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies
Silvia M. Sanz-Gonzalez, Antonio Cano, M. A. Valverde, Carlos Hermenegildo and Vicente Andres
L-Arginine Transport in Disease
Antonio Claudio Mendes Ribeiro and Tatiana M. C. Brunini
Cardiovascular Alterations After Spinal Cord Injury: An Overview
Guadalupe Bravo, Gabriel Guizar-Sahagun, Antonio Ibarra, David Centurion and Carlos M. Villalon
Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents
S. Goto
Progress in the Field of GPIIb/IIIa Antagonists
Julien Hanson, Xavier de Leval, Jean-Louis David, Claudiu Supuran, Bernard Pirotte and Jean-Michel Dogne
The Endothelium and Platelets in Cardiovascular Disease: Potential Targets for Therapeutic Intervention
K. T. Tan, S. P. Watson and G. Y.H. Lip
Cardiovascular Effects of the Phytoestrogen Genistein
Domenica Altavilla, Alessandra Crisafulli, Herbert Marini, Maria Esposito, Rosario D'Anna, Francesco Corrado, Alessandra Bitto and Francesco Squadrito
Debabrata Mukherjee
Department of Internal Medicine Texas Tech University
Biography of Debabrata Mukherjee
Debabrata Mukherjee, M.D is the Chairman of the Department of Internal Medicine and the Program Director for the Cardiovascular Medicine Fellowship program at the Texas Tech University Health Sciences Center at El Paso. Dr Mukherjee has been an invited lecturer at several major national and international meetings, has authored over 450 publications, edited eighteen textbooks on cardiovascular diseases and written more than 100 textbook chapters. He presently serves on several journal editorial boards, is the Editor-in-Chief of the Cardiovascular and Hematological Agents in Medicinal Chemistry, and the Cardiology Reviews and is an Associate Editor for the journal Cardiovascular & Hematological Disorders-Drug Targets.
⇨ Journal Home⇨ Editorial Policies⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Special Offers
Current Medicinal Chemistry - Cardiovascular & Hematological Agents was launched in 2003 and later renamed in 2006 as Cardiovascular & Hematological Agents in Medicinal Chemistry.
Frontiers in Clinical Drug Research-Hematology